Retractable Technologies (RVP)
XASE:RVP
Top Page
Retractable Technologies
(NYSE MKT:RVP)
Select Model
Select Model
Rating:48Neutral
Price Target:
$0.68
▼(-6.44% Downside)
Action:ReiteratedDate:12/31/25
The score is held down primarily by weak profitability (negative margins) and negative operating cash flow despite low leverage. Technical indicators also lean bearish with the price below key moving averages and negative MACD. Valuation offers limited support because the negative P/E reflects ongoing losses, and no common dividend yield is provided.
Positive Factors
Low Leverage / Strong Balance Sheet
Extremely low debt-to-equity (0.015) provides durable financial flexibility, reducing default and refinancing risk. This allows management to fund R&D, domestic production shifts, or absorb tariff-driven cost increases without immediate reliance on costly external financing, supporting long-term resilience.
Negative Factors
Persistent Negative Profitability
Negative gross and net margins indicate structural cost or pricing issues that erode core profitability. Continued losses limit reinvestment, constrain ability to scale, and may require pricing, product mix, or cost-structure changes to achieve sustainable operating margins over the medium term.
Read all positive and negative factors
Positive Factors
Negative Factors
Low Leverage / Strong Balance Sheet
Extremely low debt-to-equity (0.015) provides durable financial flexibility, reducing default and refinancing risk. This allows management to fund R&D, domestic production shifts, or absorb tariff-driven cost increases without immediate reliance on costly external financing, supporting long-term resilience.
Read all positive factors
Retractable Technologies (RVP) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$21.55M
Dividend YieldN/A
Average Volume (3M)153.51K
Price to Earnings (P/E)17.0
Beta (1Y)0.44
Revenue Growth-0.95%
EPS Growth58.17%
CountryUS
Employees221
SectorHealthcare
Sector Strength45
IndustryMedical - Instruments & Supplies
Share Statistics
EPS (TTM)0.01
Shares Outstanding29,937,159
10 Day Avg. Volume341,920
30 Day Avg. Volume153,511
Financial Highlights & Ratios
PEG Ratio-0.03
Price to Book (P/B)0.24
Price to Sales (P/S)0.62
P/FCF Ratio-1.59
Enterprise Value/Market Cap0.89
Enterprise Value/Revenue0.50
Enterprise Value/Gross Profit-20.81
Enterprise Value/Ebitda13.20
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Retractable Technologies Business Overview & Revenue Model
Company Description
Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. It offers Vanis...
How the Company Makes Money
Retractable Technologies generates revenue primarily through the sale of its retractable syringes and safety needle products. The company sells these products directly to healthcare providers and distributors, establishing long-term contracts and ...
Retractable Technologies Financial Statement Overview
Summary
Income Statement
45
Neutral
Balance Sheet
60
Neutral
Cash Flow
50
Neutral
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 37.90M | 33.05M | 43.60M | 94.82M | 188.38M | 81.86M |
| Gross Profit | -917.47K | -1.03M | 9.11M | 28.25M | 95.35M | 37.01M |
| EBITDA | 1.45M | 4.17M | -1.24M | 9.94M | 76.44M | 27.17M |
| Net Income | -6.45M | -11.89M | -7.01M | 5.08M | 56.06M | 24.22M |
Balance Sheet | ||||||
| Total Assets | 146.43M | 160.72M | 179.67M | 210.74M | 213.15M | 104.97M |
| Cash, Cash Equivalents and Short-Term Investments | 33.95M | 44.56M | 47.29M | 49.38M | 42.43M | 25.65M |
| Total Debt | 988.71K | 1.23M | 1.54M | 2.92M | 4.24M | 3.74M |
| Total Liabilities | 69.65M | 73.55M | 80.38M | 104.21M | 113.98M | 55.09M |
| Stockholders Equity | 76.78M | 87.17M | 99.29M | 106.54M | 99.17M | 49.88M |
Cash Flow | ||||||
| Free Cash Flow | -8.38M | -13.00M | 1.91M | -61.95K | -25.57M | -2.05M |
| Operating Cash Flow | -7.57M | -11.56M | 2.77M | 16.77M | 32.79M | 19.00M |
| Investing Cash Flow | 7.66M | 3.66M | -10.76M | -31.20M | -63.04M | -19.33M |
| Financing Cash Flow | -559.64K | -535.43K | 941.64K | 4.99M | 41.84M | 11.96M |
Retractable Technologies Technical Analysis
Positive
0.73
Price Trends
0.70
Positive
0.76
Negative
0.77
Negative
Market Momentum
<0.01
Negative
56.59
Neutral
66.33
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For RVP, the sentiment is Positive. The current price of 0.73 is above the 20-day moving average (MA) of 0.69, above the 50-day MA of 0.70, and below the 200-day MA of 0.77, indicating a neutral trend. The MACD of <0.01 indicates Negative momentum. The RSI at 56.59 is Neutral, neither overbought nor oversold. The STOCH value of 66.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for RVP.
Retractable Technologies Risk Analysis
Retractable Technologies disclosed 17 risk factors in its most recent earnings report. Retractable Technologies reported the most risks in the "Macro & Political" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Retractable Technologies Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
51 Neutral | $212.91M | -2.59 | -18.58% | ― | -43.95% | -620.21% | |
48 Neutral | $21.55M | 16.98 | -8.13% | ― | -0.95% | 58.17% | |
47 Neutral | $178.94M | -9.67 | -249.40% | ― | 19.61% | -3.42% | |
44 Neutral | $163.88M | -2.26 | -127.51% | ― | 30.55% | -340.19% | |
42 Neutral | $22.57M | -8.10 | -164.78% | ― | 0.59% | -39.76% |
* Healthcare Sector Average
RVP
Retractable Technologies
0.72
-0.03
-4.51%
OSUR
Orasure Technologies
3.08
-0.41
-11.75%
STXS
Stereotaxis
1.84
-0.14
-7.07%
MLSS
Milestone Scientific
0.29
-0.80
-73.67%
SMTI
Sanara MedTech
18.34
-12.86
-41.22%
STSS
Sharps Technology, Inc.
1.83
-44.91
-96.08%
Retractable Technologies Corporate Events
Dividends
Retractable Technologies Declares Dividend on Convertible Preferred Shares
Positive
Dec 30, 2025
On December 30, 2025, Retractable Technologies announced that it declared a dividend for holders of its Series II and Series III Class B Convertible Preferred Stock. The dividend declaration affects this specific class of preferred shareholders an...
Business Operations and StrategyFinancial Disclosures
Retractable Technologies Reports Q3 2025 Financial Results
Neutral
Nov 14, 2025
On November 14, 2025, Retractable Technologies reported its financial results for the third quarter of 2025, showing net sales of $10.1 million and an operating loss of $3.7 million, compared to $10.3 million in sales and a $5.1 million loss in th...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.